| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |